NeoBioMed Services founded in May 2006 is a Partnership Firm incorporated in India under the Indian Companies Act, 1956, and now governed under the Companies Act 2013 and having its registered office in New Delhi, India. The company is led by a management team headed by its Chief Executive Officer Dr. Brij M. Gandhi, a scientist and a technocrat with more than 47 years of experience as scientist, science manager and policy administrator with the Government of India, and consultant and service provider.
The Company has been engaged, since 2006, in providing expert technical, regulatory compliance, business support and technical services to Small and Mid-Size industries including Pharmaceutical, Biotechnology, Stem Cell & Regenerative Medicine, Biologics, Diagnostic, Medical Devices, Allied Health Industries and biodefense industries.
The company helps in obtaining Government regulatory approvals and providing complete solutions for import and export of bulk drugs, APIs, other intermediaries and chemicals including the regulatory issues involving government dealings, registration of the products and marketing authorizations, technology transfer, entry India issues etc. It helps in securing registration of manufacturing plant of Bulk drugs, products and formulations for ultimate Import of the drugs into the country; Grant of test license for drugs, approvals of Protocols for BE / CT and issues of final permissions for Manufacturing & Marketing of Bulk drugs & Formulations, Issue of Import license, Export permission for drugs.
NeoBioMed Services help in developing any commercial relations with an Indian pharma / biopharma / medical device company adhering to International standards and norms and WHO-GMP and may require interactions with concerned ministries of the government, trade missions for business development. NeoBioMed in partnerships provides quality solutions and consulting services through partner companies and business associates having successful and proven track records and have extensive knowledge and experience pertaining to their respective fields of expertise. Services includes Complete state of the art laboratory services for experimental genomics/ clinical and molecular biology services, Next Generation Sequencing (NGS) services, data analysis services; Comprehensive DNA and Genetic diagnostic services of Cytogenetic, Molecular Diagnostics, Microarray Analysis and Next Gen Sequencing for pediatrics, pre-natal, infertility, oncology and other medical specialties;
The Company provides necessary help in writing grants and securing funds from government departments and obtaining necessary clearances from the concerned departments for recognition of the laboratories and facilities. NeoBioMed Services is committed to developing Global databases for scholars, students, institutions and industries on Academic Institutions, Universities, Healthcare and Life Sciences Industry in Biotechnology, Chemicals and Biologicals, Pharmaceuticals, Regenerative Medicine and related equipment and products.